A Guide to Treatments That Work

Abstract

Back to table of contents Previous article Next article Book ReviewFull AccessA Guide to Treatments That WorkJacob H. Jacoby, M.D., Ph.D.Jacob H. JacobySearch for more papers by this author, M.D., Ph.D.Published Online:1 Oct 1999https://doi.org/10.1176/ps.50.10.1365AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail As the jacket of A Guide to Treatments That Work indicates, this comprehensive volume (594 fine-print, double-column pages and tables) assembles a distinguished group of 61 psychiatrists and clinical psychologists to take stock "of current drug treatment and psychotherapeutic interventions to see which treatments actually work, which do not, and which still remain beyond the scope of our current knowledge." To accomplish this daunting and important task, "All available outcome and clinical trials are reviewed, and detailed specification of methods and procedures to ensure effective treatment for each major DSM-IV disorder is provided." The volume encompasses 28 chapters as well as a 12-page "Summary of Treatments That Work" presented at the beginning of the book.The editors provide chapters for all of the DSM-IV categories that have known treatments. The pattern is to provide two chapters—one discussing pharmacologic treatment approaches and the other discussing nonpharmacologic or psychosocial treatment approaches—for disorders for which both types of therapies exist; some disorders are covered in only one chapter. The purpose of the chapters is to present the most rigorous, scientifically based evidence for the efficacy of treatments that is available.As the editors point out in their enlightening introductory chapter, "It is clear that for some disorders there are treatments widely recognized by experienced clinicians to be useful that may not have been subjected to rigorous investigation." The aim of this book is "to be clear with readers what treatments have been scientifically validated, what treatments are felt by a large number of experts to be valuable but have never been properly scientifically examined, and what treatments are known to be of little value."The origins of the book are not without history and controversy, as is cogently noted in both the foreword and the afterword by Martin E. P. Seligman. Dr. Seligman was president of the American Psychological Association's division of clinical psychology in the mid-1990s when he created a task force to review well-done, controlled outcome studies and identify "treatments that work" (1). The history relates to a progression of outcome studies dating from Eysenck's 1952 landmark paper (2), "The Effects of Psychotherapy," in which no evidence of psychotherapy's effectiveness was noted, to more current and increasingly positive evaluations of both psychotherapy outcomes and the methodologic rigor used in their assessment. Today we are moving closer to recognizing which psychotherapeutic or pharmacologic approach is most effective for which person and in which treatment setting.The controversy relates to the fear, beginning with the development of this book, that if it were an "official" document of the division, it might imply that the American Psychological Association endorsed its contents. We have seen the development of a level of confidence in treatment approaches that has now blossomed into "empirically supported treatment guidelines" published by the American Psychological Association (3) and "practice guidelines" published by the American Psychiatric Association—for instance, the American Psychiatric Association's guidelines for major depressive disorders in 1993 (4), for bipolar disorders in 1994 (5), and for substance use disorders in 1995 (6), followed by others. However, one should note that this level of confidence in guidelines may not always be warranted. They can stifle other therapeutic approaches less amenable to the research paradigms currently used, or they may be employed in a clinically restrictive way by contemporary care (that is, cost) managers.Be that as it may, this book represents an invaluable update of contemporary psychotherapeutic, including psychopharmacologic, treatments of DSM-IV psychiatric disorders. It will be useful for both the academician and the practicing clinician and will be referred to frequently by its appreciative owner.Dr. Jacoby is codirector of the department of psychiatry at Bayonne (N.J.) Hospital and clinical associate professor of psychiatry at the University of Medicine and Dentistry of New Jersey in Newark.edited by Peter E. Nathan, Ph.D., and Jack M. Gorman, M.D.; New York City, Oxford University Press, 1998, 594 pages, $75